Lupus anticoagulant and ischemic myocardial microangiopathy in rheumatoid arthritis

Nature Clinical Practice Cardiovascular Medicine

Volumn 3, Issue 6, 2006, Pages 339-343

  Ferraccioli, Gianfranco ^a   Zoli, Angelo ^a   Alivernini, Stefano ^a   De Santis, Maria ^a   Verrillo, Alfonso ^a   Loperfido, Francesco ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Ischemic microangiopathy; Lupus anticoagulant; Rheumatoid arthritis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CYCLOSPORIN; INFLIXIMAB; LUPUS ANTICOAGULANT; METHOTREXATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PREDNISOLONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; COUGHING; DISEASE EXACERBATION; DRUG DOSE REGIMEN; DYSKINESIA; DYSPNEA; ECHOCARDIOGRAPHY; HEART MUSCLE ISCHEMIA; HEART SCINTISCANNING; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MALE; MICROANGIOPATHY; POLYARTHRITIS; PRIORITY JOURNAL; RETROSTERNAL PAIN; RHEUMATOID ARTHRITIS; STRESS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ASPIRIN; ECHOCARDIOGRAPHY; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LUPUS COAGULATION INHIBITOR; MALE; METHOTREXATE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION INHIBITORS; PREDNISOLONE; SIALOGLYCOPROTEINS; TICLOPIDINE;

EID: 33744531367     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio0576     Document Type: Article

References (11)

1. Gonzalez-Gay MA et al. (2005) Rheumatoid Arthritis: A disease associated with accelerated Atherogenesis. Semin Arthritis Rheum 35: 8-17
2. del Rincon ID et al. (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44: 2737-2745
3. Nomura M et al. (1994) Renal thrombotic microangiopathy in a patient with rheumatoid arthritis and antiphospholipid syndrome: Successful treatment with cyclophosphamide pulse therapy and anticoagulant. Intern Med 33: 484-487
4. Petri M (2004) The lupus anticoagulant is a risk factor for myocardial infarction (but not atherosclerosis): Hopkins Lupus Cohort. Thromb Res 114: 593-595
5. Tenedios F et al. (2005) Cardiac involvement in the antiphospholipid syndrome. Lupus 14: 691-696
6. Miyakis S et al. (2006) International Consensus Statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4: 295-306
7. Fleischmann R et al. (2004) Anakinra: An inhibitor of IL-1 for the treatment or rheumatoid arthritis. Expert Opin Biol Ther 4: 1333-1334
8. Chen ZM et al. (2005) COMMIT (Clopidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: Randomised placebo-controlled trial. Lancet 366: 1607-1621
9. Booth AD et al. (2004) Infliximab improves endothelial dysfunction in systemic vasculitis: A model of vascular inflammation. Circulation 109: 1718-1723
10. Ferraccioli GF and Gremese E (2004) Autoantibodies and thrombophilia in RA: TNFα and TNFα blockers. Ann Rheum Dis 63: 613-615
11. Ferraro-Peyret C et al. (2004) Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: A two-year prospective study. Arthritis Res Ther 6: R535-R543